TerminatedNCT01929889
Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia
Medication studyAges 18–55United States
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- ChicagoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 19
- Sponsor
- Northwestern University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT01929889
- Official title
Show the full official title
An Exploratory Study to Assess the Effects of Fanapt® on Social Cognitive Performance
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwestern University, a university.
Does this study involve medication?
Yes. The study involves medication, including Iloperidone.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)